Clinical Reasoning: A Young Woman With Rapidly Progressive Weakness and Paresthesia.

Neurology

From the College of Medicine (S.S.A., F.A.A.), and Neurology Unit (A.Y.A., S.A.), Department of Medicine, King Saud University, Riyadh, Saudi Arabia.

Published: October 2023

A 24-year-old Middle Eastern woman presented with a 2-month history of rapidly progressive asymmetric weakness and paresthesia that began in her left lower extremity and progressed to involve both legs and arms. It was associated with overflow urinary incontinence and significant weight loss. In addition, she complained of a constant occipital headache that worsened in the supine position and was associated with photophobia, tinnitus, nausea, vomiting, and horizontal binocular diplopia. She also had signs of meningismus, decreased left facial sensation, and right sensorineural hearing loss. Because multifocal localization suggests a wide variety of possible differential diagnoses, this study expands on the differential of a subacute multifocal process while highlighting the importance of identifying appropriate risk factors and performing a relevant yet focused diagnostic workup.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585685PMC
http://dx.doi.org/10.1212/WNL.0000000000207662DOI Listing

Publication Analysis

Top Keywords

rapidly progressive
8
weakness paresthesia
8
clinical reasoning
4
reasoning young
4
young woman
4
woman rapidly
4
progressive weakness
4
paresthesia 24-year-old
4
24-year-old middle
4
middle eastern
4

Similar Publications

Optimizing combination targeted immunotoxin therapy: Insights from HER2 and EpCAM expression profiles.

Biochem Biophys Res Commun

December 2024

Moscow Center for Advanced Studies, Kulakova Str. 20, 123592, Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya St., 117997, Moscow, Russia. Electronic address:

Molecular targeted cancer therapy is a rapidly developing field, driving progress toward greater treatment efficacy. However, targeted monotherapy often fails due to the development of multidrug resistance in tumors. The combination of multiple targeted agents emerges as a possible solution to enhance treatment outcomes by activating different signaling pathways.

View Article and Find Full Text PDF

Objectives: This study aimed to evaluate the incidence and clinical significance of coexistence of anti-aminoacyl-tRNA synthetase (anti-ARS) antibody in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis (anti-MDA5 + DM).

Methods: We assessed a cohort of 246 consecutive patients with anti-MDA5 + DM. Clinical characteristics and survival rates were compared between patients with and without anti-ARS antibodies.

View Article and Find Full Text PDF

BACT: nonparametric Bayesian cell typing for single-cell spatial transcriptomics data.

Brief Bioinform

November 2024

Institute of Statistics and Big Data, Renmin University of China, No. 59 Zhongguancun Street, 100872 Beijing, China.

The spatial transcriptomics is a rapidly evolving biological technology that simultaneously measures the gene expression profiles and the spatial locations of spots. With progressive advances, current spatial transcriptomic techniques can achieve the cellular or even the subcellular resolution, making it possible to explore the fine-grained spatial pattern of cell types within one tissue section. However, most existing cell spatial clustering methods require a correct specification of the cell type number, which is hard to determine in the practical exploratory data analysis.

View Article and Find Full Text PDF

Background: The term rapidly progressive dementia (RPD) may be applied to patients with precipitous declines in cognitive function resulting in dementia within one year or complete incapacitation within two-years of symptom onset. Although most patients present with subacute, progressive declines, selected patients develop complete incapacitation within seven days of symptom onset. The differential diagnosis and clinical characteristics of patients with abrupt-onset dementia are not known.

View Article and Find Full Text PDF

Background: Pathological tau aggregates cause cognitive decline in neurodegenerative tauopathies, including Alzheimer's disease (AD), and more abundant in intracellular vs. extracellular compartments. However, current immunotherapies are slow and ineffective at clearing intracellular tau aggregates.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!